Opdualag ইউরোপীয় ইউনিয়ন - লিথুয়েনীয় - EMA (European Medicines Agency)

opdualag

bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanoma - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.

Sotyktu ইউরোপীয় ইউনিয়ন - লিথুয়েনীয় - EMA (European Medicines Agency)

sotyktu

bristol-myers squibb pharma eeig - deucravacitinib - psoriazė - imunosupresantai - treatment of moderate-to-severe plaque psoriasis in adults.

Dysport লিত্ভা - লিথুয়েনীয় - SMCA (Valstybinė vaistų kontrolės tarnyba)

dysport

adeofarma, uab - clostridium botulinum a tipo toksino ir hemagliutinino kompleksas - milteliai injekciniam tirpalui - 500 v - botulinum toxin